赵燕霞，于立明. 99mTc-MIBI显像阴性甲状旁腺癌致甲状旁腺功能亢进症1例[J]. 中国临床医学影像杂志, 2020, 31(1): 67-69.
ZHAO Yan-xia, YU Li-ming. Negative of 99mTc-MIBI imaging in hyperparathyroidism caused by parathyroid carcinoma: report of one case. JOURNAL OF CHINA MEDICAL IMAGING, 2020, 31(1): 67-69.
[1]Dudney WC, Bodenner D, Stack Jr BC. Parathyroid carcinoma[J]. Otolaryngol Clin North Am, 2010, 43(2): 441-453.
[2]Schaapveld M, Jorna FH, Aben KK, et al． Incidence and prognosis of parathyroid gland carcinoma: a population-based study in the Netherlands estimating the preoperative diagnosis[J]. Am J Surg, 2011, 202(5): 590-597．
[3]Cakal E, Cakir E, Dilli A, et al. Adenoma screening efficacies of different imaging tools and factors affecting the SUCCESS rates[J]. Clin Imaging, 2014, 36(3): 688-694．
[4]刘轶敏，陈黎波，李焱文，等. 99mTc-MIBI和99mTcO4-显像定位诊断甲状旁腺机能亢进[J]. 中国医学影像技术，2006，22（8）：1243-1246.
[5]季红，金常青，于建芳，等. 99mTc-MIBI诊断甲状旁腺癌1例[J]. 中国医学影像技术，2009，25（11）：1999.
[6]游金辉，张涛，吴晓华，等. 甲状旁腺癌伴甲状旁腺功能亢进99mTc-MIBI双时相显像一例[J]. 中华核医学杂志，2004，24（3）：180.
[7]Sun SS, Shiau YC, Lin CC, et al. Correlation between parathyroid p-glycoprotein(p-gp) expression and Tc-99m MIBI parathyroid imaging findings[J]. Nucl Med Biol, 2001, 28(8): 929-933.
[8]Moretti JL, Duran-Cordobes M, Starzec A, et al. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells[J]. Nucl Med, 1998, 39(7): 1214-1218.
[9] Thanseer NTK, Parihar AS, Sood A, et al. Evaluation of recurrent parathyroid carcinoma: A new imaging tool in uncommon entity[J]. World J Nucl Med, 2019, 18(2): 198-200.
[10]世杰，张大奇，边学海，等. 99mTc-MIBI双时相显像及超声对原发性甲状旁腺功能亢进症的定位诊断价值[J]. 中国实验诊断学，2011，15（2）：345-346.
